financetom
Business
financetom
/
Business
/
Bandhan Bank Q2 profit down 5% at Rs 920 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bandhan Bank Q2 profit down 5% at Rs 920 cr
Nov 2, 2020 6:16 AM

Bandhan Bank on Monday reported 5.3 percent decline in net profit at Rs 920 crore for September quarter of the current fiscal year. The bank clocked a net profit of Rs 971.80 crore in the same period of 2019-20.

Total income grew 22 percent to Rs 2,304.90 crore in July-September 2020-21 as against Rs 1,889.30 crore in the year-ago period, Bandhan Bank said in a regulatory filing. Net interest income of the Kolkata-headquartered lender jumped 25.8 percent to Rs 1,923.1 crore during the quarter while the non-interest income grew 6.1 percent to Rs 381.8 crore.

Bandhan Bank said it has reported the highest ever quarterly profit before tax at Rs 1,233 crore during the period under review. Net Interest Margin (annualised) in the quarter fell to 8 percent against 8.2 percent in year-ago period. During the quarter, the bank took accelerated additional provision on standard advances amounting to Rs 300 crore. With this provision and the additional standard assets provision that bank is carrying in micro banking portfolio, the total additional provision in books stands at Rs 2,096 crore, it said.

The bank’s gross non-performing assets fell to 1.2 percent (Rs 874 crore) of gross advances as of September 30, 2020 as against 1.8 percent (Rs 1,064.20 crore) by the year-ago same period. Net NPAs too improved to 0.4 percent (Rs 262.50 crore) from 0.6 percent (Rs 336.90 crore).

”As the moratorium ended on 31st August 2020 coupled with robust rural performance, we have seen an all-round improvement in collection, disbursement and deposits. On deposits front, we have witnessed the best ever quarter whereas on the disbursement front, we are close to pre-COVID-19 level.”

Collections have seen a steady improvement month-on-month and is expected to reach near normal in the next 90 days. We now look forward to accelerate the business in H2FY 21,” Managing Director and CEO Chandra Shekhar Ghosh said. Total Advances grew 19.4 percent to Rs 76,614.6 crore as on September 30, 2020. Total deposits increased 34.4 percent to Rs 66,127.7 crore.

Bandhan Bank stock was trading at Rs 305.50 on BSE, up 5.62 percent from the previous close.

First Published:Nov 2, 2020 3:16 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Analog chipmaker Texas Instruments forecasts quarterly revenue above estimates
Analog chipmaker Texas Instruments forecasts quarterly revenue above estimates
Apr 23, 2024
April 23 (Reuters) - Chipmaker Texas Instruments forecast second-quarter revenue above Wall Street estimates on Tuesday, as consumer electronics demand improved after months of declines, more than offsetting the impact from chip inventory corrections in the automotive market. The Dallas, Texas-based company expects revenue with a midpoint of $3.8 billion for the quarter, compared with analysts' average estimate of $3.77...
Five Eyes countries working to fight critical minerals dumping, Canada minister says
Five Eyes countries working to fight critical minerals dumping, Canada minister says
Apr 23, 2024
TORONTO, April 23 (Reuters) - Canada and its Five Eyes Alliance partners are working on put forward a response to tackle the price manipulation of critical metals, Canada's Finance Minister Chrystia Freeland said on Tuesday. The U.S., Britain, Canada, Australia and New Zealand have what is called the Five Eyes intelligence sharing network and the finance ministers from these countries...
Toymaker Mattel's quarterly loss smaller than expected as cost cuts pay off
Toymaker Mattel's quarterly loss smaller than expected as cost cuts pay off
Apr 23, 2024
* Reaffirms full-year sales and profit forecasts * CEO says off to a good start for the year * MAT posts Q1 adj loss of 5 cents/shr vs est. of 12 cents/shr * Reports Q1 sales of $809.5 mln vs est. of $831.8 mln By Granth Vanaik April 23 (Reuters) - Mattel ( MAT ) posted a smaller-than-expected loss for...
Day One Biopharmaceuticals Shares Rise; FDA Issues Accelerated Approval for Pediatric Low-Grade Glioma Treatment
Day One Biopharmaceuticals Shares Rise; FDA Issues Accelerated Approval for Pediatric Low-Grade Glioma Treatment
Apr 23, 2024
03:54 PM EDT, 04/23/2024 (MT Newswires) -- Day One Biopharmaceuticals ( DAWN ) shares rose 10% in recent Tuesday trading after the company's Ojemda received accelerated approval from the US Food and Drug Administration for the treatment of patients six months and older with relapsed or refractory pediatric low-grade glioma harboring a BRAF fusion or rearrangement, or BRAF V600 mutation....
Copyright 2023-2026 - www.financetom.com All Rights Reserved